PT Indofarma Tbk reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was IDR 363,965.08 million compared to IDR 574,053.82 million a year ago. Net loss was IDR 120,346.04 million compared to IDR 90,715.02 million a year ago.

Basic loss per share from continuing operations was IDR 38.83 compared to IDR 29.27 a year ago.